Want to create an interactive transcript for this episode?
Podcast: Learning With Lowell
Episode: targeting the mechanisms of treatment resistance in cancer with Nicholas Goldner | 222
Description: Nicholas Goldner, PhD, is the CEO and co-founder of resistanceBio, where he leads a mission to outsmart cancer by developing innovative therapies targeting treatment resistance mechanisms. He also serves as a venture partner at Pioneer Fund, actively investing in and supporting early-stage founders solving complex problems with science and technology. With a distinguished academic background, including a PhD in Molecular Cell Biology from Washington University in St. Louis, Nicholas combines scientific expertise with entrepreneurial prowess to create impactful solutions for pressing health challenges.
Newsletter sign up (new and exciting developments)
https://learningwithlowell.us12.list-manage.com/subscribe?u=08ed8a56013d8...